Jared Kaltwasser

Jared is a freelance writer for The American Journal of Managed Care® (AJMC®), and previously worked as a senior editor for HCPLive® at MJH Life Sciences®.

He has an MA from University of Sioux Falls. You can connect with Jared on LinkedIn.

Articles by Jared Kaltwasser

Wave of Targeted CLL Therapies Raises Questions About Autoimmune Complications

ByJared Kaltwasser

February 5th 2020

New targeted therapies like ibrutinib, idelalisib, and venetoclax appear to be highly successful in the treatment of chronic lymphocytic leukemia (CLL), but investigators say it’s unclear how those therapies impact autoimmune complications of the cancer.

Jared Kaltwasser

Articles by Jared Kaltwasser

Wave of Targeted CLL Therapies Raises Questions About Autoimmune Complications

Trending on AJMC

Medicare State Rankings Reveal Stark Differences in Access, Quality, and Affordability

Abemaciclib Plus Endocrine Therapy Improves Overall Survival in High-Risk Early Breast Cancer

Real-World Data Show Preventive Nirsevimab Reduces Infant RSV Hospitalizations

New Biomarkers, Drug Targets Identified for Colorectal Cancer

First-Line Zongertinib Yields Strong Responses in Patients With Advanced HER2-Mutant NSCLC